Ideal Taxes Association

Raymond Richman       -       Jesse Richman       -       Howard Richman

 Richmans' Trade and Taxes Blog



Four questions that senators should ask Redfield and Fauci on Tuesday - I'm published in the American Thinker this morning
Howard Richman, 5/10/2020

On Tuesday, health bureaucrats Dr. Robert Redfield, director of the CDC, and Dr. Anthony Fauci, director of NIAID, will testify at a hearing of the Senate Health, Education, Labor and Pensions Committee. Republican Senators should ask them four questions about their failures to expedite deployment of vaccines and test the successful HCQ-zinc treatment during the COVID-19 pandemic.

1. Vaccine question for Redfield: Why haven’t you invoked the Accelerated Approval Process to get Moderna’s Vaccine out right away?

During the H1N1 (Swine Flu) epidemic in 2009 when a Democrat was President, the CDC approved four vaccines just 7 weeks after clinical trials began by invoking the Accelerated Approval Process. Here are excerpts from the timeline on their website:

  • April 15. First human infection.
  • May 5. School closings affect 607,778 students.
  • July 22. Clinical trials testing the vaccines begin.
  • September 15. Four H1N1 vaccines approved for use by the FDA.

In this accelerated process, designed for epidemics, a single clinical trial phase determines whether a vaccine is safe and whether it creates the required antibodies. In vaccine terminology, the pathogen-specific antibodies developed by a vaccine are considered to be a “surrogate endpoint” permitting the vaccine to be deployed immediately, without Phase 2 or Phase 3 studies. A “Phase 4” process begins after deployment to track the effectiveness and the side-effects of the vaccine.

On May 7, the FDA announced that Moderna’s coronavirus vaccine had been approved to begin its Phase 2 trial. Since its Phase 1 clinical trial concluded successfully, it is safe for healthy people and able to produce a “surrogate endpoint.” As a result, it could be immediately deployed to healthy people in order to create the 60% herd immunity condition that prevents spread of an epidemic.

Moderna’s Phase 2 clinical trial is scheduled to end mid-summer which will determine whether the vaccine is safe for older people and other groups that would have high mortality rate should they contract COVID-19. If this trial is successful, use of Moderna’s vaccine could immediately be extended to those less-healthy groups.

There are several additional Covid-19 vaccines waiting in the wings, all of which could be tested quickly if the CDC would simply put the Accelerated Approval Process into place today, just as they did in 2009.

2. Vaccine Question for Fauci: Why did you tie up Inovio’s vaccine in a year-long Phase 1 clinical trial?

Inovio Pharmaceuticals was the first company to create a COVID-19 vaccine. Then they made the mistake of agreeing to Fauci’s offer to test their vaccine for free, perhaps not realizing that NIAID planned to tie it up in a year-long Phase 1 clinical trial. Fortunately for the world, Moderna saw what happened to Inovio and avoided making that mistake.

3. Treatment Question for Redfield: Why haven’t you tested HCQ (hydroxychloroquine) with a zinc supplement for early treatment of COVID-19?

When the H1N1 epidemic hit. The CDC quickly tested every promising drug for use in treating the virus. In contrast, when COVID-19 hit, Redfield’s CDC didn’t even bother to conduct clinical trials on those drugs that had worked abroad. Fortunately, Internet research is available to all doctors, and HCQ is a well-known safe drug that is already prescribed for daily use by lupus patients, so many physicians have been prescribing HCQ for COVID-19.

In April, Dr. Robin Amstrong, whose medical group serves the Resort at Texas City nursing home, successfully treated 56 residents and 31 staff members who had tested positive for COVID-19. He administered HCQ with zinc supplements and an antibiotic for five days. As a result, only one of his patients and not a single staff member died. This compares favorably with the usual Case Fatality Rate of about 15% for patients who are 80 and up.

Armstrong used the same 5-day course of treatment that had been successfully used by primary care physician Dr. Vladimir Zelenko when COVID-19 raged through the New York Hasidic community that he served. If this treatment proves to be as effective as Armstrong and Zelenko report, then tens of thousands of lives could be saved.  But the CDC has not yet conducted a randomized clinical study to determine if it works.

4. Treatment Question for Fauci: Why did you leave out zinc when testing HCQ with hospitalized zinc-deficient patients?

Fauci’s NIAID has publicized two studies in which HCQ was given to seriously ill hospitalized patients without administering zinc at the same time. The patients involved were probably zinc deficient, since almost all those who die from COVID-19 are drawn from zinc deficient groups.

HCQ is a zinc-ionophore (meaning that it helps transport available zinc from the blood stream through cell walls into cells where it slows virus replication). Medical researchers from around the world are currently calling for the combo of HCQ and zinc supplements to be tested, based upon their extensive reviews of the research evidence. These researchers include:

The Belgian researchers’ conclusion is especially relevant. They found that when HCQ is administered without zinc to zinc-deficient patients, it could actually reduce the zinc in the part of the cell (the lysosome) where it can do the most good.

Dr. Jackson in this video (see 40:16 mark) reports that not one of his elderly (and thus zinc-deficient) patients experienced the worsened arrhythmias from HCQ in Fauci’s studies of hospitalized patients. In view of the 2007 finding that zinc supplementation combined with a zinc ionophore can actually reduce the incidence of heart arrhythmias, the explanation could be simple!  Jackson gave zinc supplements to his elderly patients along with the HCQ. The studies that Fauci touts did not!

Instead, of taking the time to keep up with the research regarding zinc and HCQ, Fauci talks daily on the telephone with Andrew Cuomo of anti-Trump CNN, supposedly to ask him about his health.  Meanwhile, at the CDC, instead of expediting vaccines and testing treatments, Redfield calls for mail-in voting in the next election, a measure that would benefit Democrats.

Fauci and Redfield are playing political games while Americans die. Republican Senators need to ask them why they are failing to invoke the Accelerated Approval Process to get out a vaccine right away and why they are failing to test the HCQ-zinc treatment.

To read it on the American Thinker website, go to: 

https://www.americanthinker.com/blog/2020/05/four_questions_senators_should_ask_redfield_and_fauci_on_tuesday.html

Your Name:

Post a Comment:


Comment by thxzetec, 5/20/2020:

Where are the trials?  We keep hearing there is no well controled experiment, but why wasn't one run in the last 2 months?

Compare Chloroquine to Remdesivir.   One is low-cost generic, one is owned by one company.    Which one got endorsed?  I'm not saying there is conspiract, but there was a company with incentive to push trial for remdesivir.




  • Richmans' Blog    RSS
  • Our New Book - Balanced Trade
  • Buy Trading Away Our Future
  • Read Trading Away Our Future
  • Richmans' Commentaries
  • ITA Working Papers
  • ITA on Facebook
  • Contact Us

    Archive
    May 2020

    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011
    April 2011
    March 2011
    February 2011
    January 2011
    December 2010
    November 2010
    October 2010
    September 2010
    August 2010
    July 2010
    June 2010
    May 2010
    April 2010
    March 2010
    February 2010
    January 2010

    Categories:
    Book Reviews
    Capital Gains Taxation
    Corporate Income Tax
    Consumption Taxes
    Economy - Long Term
    Economy - Short Term

    Environmental Regulation
    Last 100 Years
    Politics
    Real Estate Taxation
    Trade
    Miscellaneous

    Outside Links:

  • American Economic Alert
  • American Jobs Alliance
  • Angry Bear Blog
  • Economy in Crisis
  • Econbrowser
  • Emmanuel Goldstein's Blog
  • Levy Economics Institute
  • McKeever Institute
  • Michael Pettis Blog
  • Naked Capitalism
  • Natural Born Conservative
  • Science & Public Policy Inst.
  • TradeReform.org
  • Votersway Blog
  • Watt's Up With That


    Wikipedia:

  • [An] extensive argument for balanced trade, and a program to achieve balanced trade is presented in Trading Away Our Future, by Raymond Richman, Howard Richman and Jesse Richman. “A minimum standard for ensuring that trade does benefit all is that trade should be relatively in balance.” [Balanced Trade entry]

    Journal of Economic Literature:

  • [Trading Away Our Future] Examines the costs and benefits of U.S. trade and tax policies. Discusses why trade deficits matter; root of the trade deficit; the “ostrich” and “eagles” attitudes; how to balance trade; taxation of capital gains; the real estate tax; the corporate income tax; solving the low savings problem; how to protect one’s assets; and a program for a strong America....

    Atlantic Economic Journal:

  • In Trading Away Our Future   Richman ... advocates the immediate adoption of a set of public policy proposal designed to reduce the trade deficit and increase domestic savings.... the set of public policy proposals is a wake-up call... [February 17, 2009 review by T.H. Cate]